Market Tracker

07/21 8:37am ET

Nektar Therapeutics (NASDAQ:NKTR)

22.17
Delayed Data
As of Jul 20
 +0.51 / +2.35%
Today’s Change
11.41
Today|||52-Week Range
24.88
+80.68%
Year-to-Date

Today’s Trading

Previous close21.66
Today’s open21.75
Day’s range21.28 - 22.50
Volume1,879,344
Average volume (3 months)1,781,892
Market cap$3.4B
Dividend yield--
Data as of 07/20/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)-13.51%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book38.54

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+0.81+2.87%
XONIntrexon Corp+0.65+2.83%
NBIXNeurocrine Bioscienc...+0.06+0.13%
AVXSAveXis Inc-0.04-0.05%
Data as of 07/20/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts